Walgreens Boots Alliance (WBA) Receives “Peer Perform” Rating from Wolfe Research

Share on StockTwits

Walgreens Boots Alliance (NASDAQ:WBA)‘s stock had its “peer perform” rating reissued by investment analysts at Wolfe Research in a report released on Wednesday, December 19th, MarketBeat reports.

Other equities research analysts have also recently issued reports about the company. TheStreet upgraded Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research note on Wednesday, September 12th. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price target on the stock in a report on Tuesday, September 25th. BidaskClub lowered Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a report on Tuesday, August 28th. Loop Capital raised their price target on Walgreens Boots Alliance from $80.00 to $82.00 and gave the company a “buy” rating in a report on Friday, October 12th. Finally, Barclays raised their price target on Walgreens Boots Alliance from $77.00 to $80.00 and gave the company an “equal weight” rating in a report on Friday, October 12th. Three analysts have rated the stock with a sell rating, twelve have assigned a hold rating and five have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $79.35.

WBA traded down $0.77 during trading hours on Wednesday, hitting $71.71. 5,678,554 shares of the stock were exchanged, compared to its average volume of 6,014,670. Walgreens Boots Alliance has a 12 month low of $59.07 and a 12 month high of $86.31. The stock has a market capitalization of $68.15 billion, a PE ratio of 11.91, a price-to-earnings-growth ratio of 1.13 and a beta of 0.99. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.80 and a quick ratio of 0.36.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, December 20th. The pharmacy operator reported $1.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.43 by $0.03. The firm had revenue of $33.79 billion for the quarter, compared to analysts’ expectations of $33.90 billion. Walgreens Boots Alliance had a return on equity of 22.17% and a net margin of 3.96%. The firm’s revenue for the quarter was up 9.9% on a year-over-year basis. During the same period last year, the business posted $1.28 earnings per share. As a group, research analysts anticipate that Walgreens Boots Alliance will post 6.52 earnings per share for the current fiscal year.

In other Walgreens Boots Alliance news, EVP Kathleen Wilson-Thompson sold 52,000 shares of the firm’s stock in a transaction dated Wednesday, October 31st. The stock was sold at an average price of $78.77, for a total transaction of $4,096,040.00. Following the completion of the sale, the executive vice president now directly owns 81,076 shares in the company, valued at approximately $6,386,356.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Nancy M. Schlichting sold 7,050 shares of the firm’s stock in a transaction dated Tuesday, November 20th. The stock was sold at an average price of $78.81, for a total value of $555,610.50. Following the sale, the director now owns 5,709 shares of the company’s stock, valued at $449,926.29. The disclosure for this sale can be found here. Insiders sold a total of 73,756 shares of company stock valued at $5,824,194 in the last quarter. 15.73% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. raised its stake in shares of Walgreens Boots Alliance by 0.6% in the 3rd quarter. Vanguard Group Inc. now owns 70,634,071 shares of the pharmacy operator’s stock valued at $5,149,224,000 after acquiring an additional 448,045 shares in the last quarter. Vanguard Group Inc raised its stake in shares of Walgreens Boots Alliance by 0.6% in the 3rd quarter. Vanguard Group Inc now owns 70,634,071 shares of the pharmacy operator’s stock valued at $5,149,224,000 after acquiring an additional 448,045 shares in the last quarter. BlackRock Inc. raised its stake in shares of Walgreens Boots Alliance by 1.5% in the 2nd quarter. BlackRock Inc. now owns 53,148,612 shares of the pharmacy operator’s stock valued at $3,189,715,000 after acquiring an additional 771,307 shares in the last quarter. Franklin Resources Inc. raised its stake in shares of Walgreens Boots Alliance by 21.5% in the 3rd quarter. Franklin Resources Inc. now owns 18,789,390 shares of the pharmacy operator’s stock valued at $1,369,796,000 after acquiring an additional 3,318,524 shares in the last quarter. Finally, Capital World Investors raised its stake in shares of Walgreens Boots Alliance by 18.2% in the 3rd quarter. Capital World Investors now owns 18,089,012 shares of the pharmacy operator’s stock valued at $1,318,689,000 after acquiring an additional 2,790,213 shares in the last quarter. Hedge funds and other institutional investors own 62.98% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Story: What are the components of an earnings report?

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply